GERRI DYER: Open Payments
NPI 1952328486 · HERRIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 47 payments from 15 companies in 2025. Trend: 2023 $1,560 · 2024 $1,334 · 2025 $1,199
Food & beverage: $1,099Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $238 |
| Incyte Corporation | 4 | $198 |
| Galderma Laboratories, L.P. | 5 | $182 |
| ABBVIE INC. | 5 | $116 |
| Janssen Biotech, Inc. | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| Lilly USA, LLC | 4 | $76 |
| UCB, Inc. | 2 | $41 |
| GENZYME CORPORATION | 1 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
Products named: OTEZLA, OPZELURA, NEMLUVIO, SKYRIZI, TREMFYA, COSENTYX, TALTZ, Bimzelx.
Industry payments across IL — which companies pay providers there.
